OIT and Xolair® (Omalizumab) in Cow's Milk Allergy

NCT01157117 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

77

Enrollment

OTHER

Sponsor class

Conditions

Milk Allergy

Interventions

BIOLOGICAL: Placebo for omalizumab
BIOLOGICAL: Omalizumab
DRUG: Milk powder

Sponsor

Hugh A Sampson, MD

Collaborators

[object Object]